Nutraceuticals to Improve Lipid Profile in European Countries

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01649986

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01649986
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01649986. Randomized; quadruple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nutraceuticals to Improve Lipid Profile in European Countries
Acronym
PIN
Condition
Hyperlipidemia
Intervention (Behavioral)
Non-pharmacologic intervention
Intervention (Drug)
Nutraceuticals (Armolipid Plus)
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01649986
Content hash
9206be8624037232cbc5ca8b73db58b1256514227f66b1fb0f2a18aacea35657